ADCY1 Gene

ADCY1 Gene

Introduction

Adcy1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>ADCY1</td></tr>
<tr><th>Full Name</th><td>Adenylate Cyclase 1</td></tr>
<tr><th>Chromosomal Location</th><td>5p15.32</td></tr>
<tr><th>NCBI Gene ID</th><td>107</td></tr>
<tr><th>OMIM</th><td>612119</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000164742</td></tr>
<tr><th>UniProt ID</th><td>Q08828</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, Intellectual Disability, Autism Spectrum Disorder</td></tr>
</table>
</div>

Overview

ADCY1 (Adenylate Cyclase 1), also known as AC1 or ADCY1, encodes a calcium/calmodulin-activated adenylate cyclase that catalyzes the conversion of ATP to cyclic AMP (cAMP)[@hanoune2001]. This enzyme is a key component of neuronal signaling pathways, particularly in regions associated with learning and memory. ADCY1 is one of nine adenylate cyclase isoforms in humans and is unique in its direct activation by calcium-calmodulin complex, making it a critical sensor of calcium signaling in [neurons](/entities/neurons)[@xia2018].

Function

Catalytic Activity

Adenylate cyclase 1 is a membrane-bound enzyme that catalyzes the production of cAMP:

ADCY1 Gene

Introduction

Adcy1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>ADCY1</td></tr>
<tr><th>Full Name</th><td>Adenylate Cyclase 1</td></tr>
<tr><th>Chromosomal Location</th><td>5p15.32</td></tr>
<tr><th>NCBI Gene ID</th><td>107</td></tr>
<tr><th>OMIM</th><td>612119</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000164742</td></tr>
<tr><th>UniProt ID</th><td>Q08828</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, Intellectual Disability, Autism Spectrum Disorder</td></tr>
</table>
</div>

Overview

ADCY1 (Adenylate Cyclase 1), also known as AC1 or ADCY1, encodes a calcium/calmodulin-activated adenylate cyclase that catalyzes the conversion of ATP to cyclic AMP (cAMP)[@hanoune2001]. This enzyme is a key component of neuronal signaling pathways, particularly in regions associated with learning and memory. ADCY1 is one of nine adenylate cyclase isoforms in humans and is unique in its direct activation by calcium-calmodulin complex, making it a critical sensor of calcium signaling in [neurons](/entities/neurons)[@xia2018].

Function

Catalytic Activity

Adenylate cyclase 1 is a membrane-bound enzyme that catalyzes the production of cAMP:

• Reaction: ATP → cAMP + PPi (pyrophosphate)
• Activation: Calcium-calmodulin complex (Ca²⁺-CaM) directly activates AC1
• G-protein regulation: Also activated by Gsα subunits from [G-protein coupled receptors](/mechanisms/gpcr-signaling)
• Regional expression: Highest in [hippocampus](/brain-regions/hippocampus), cerebral [cortex](/brain-regions/cerebral-cortex), and [cerebellum](/brain-regions/cerebellum)

Key Biological Roles

Disease Associations

Alzheimer's Disease

ADCY1 plays a complex role in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis[@zhang2019]:

• [Amyloid-beta](/proteins/amyloid-beta) effects: [Aβ](/proteins/amyloid-beta) peptides impair AC1 activity and downstream [PKA/CREB signaling](/mechanisms/creb-signaling), contributing to memory deficits
• cAMP dysregulation: Altered cAMP signaling observed in AD brain correlates with cognitive decline
• Therapeutic targeting: AC1 modulators may enhance cognitive function by boosting cAMP/PKA activity
• Synaptic dysfunction: Reduced AC1 activity contributes to impaired synaptic plasticity

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease)[@lee2020]:

• Dopaminergic signaling: [D1 dopamine receptors](/proteins/drd1-protein) signal through AC1 to regulate motor control
• Striatal dysfunction: Altered striatal cAMP signaling contributes to motor symptoms
• Neuroprotection: AC1 activity may be neuroprotective in dopaminergic neurons

Intellectual Disability and Autism

• ADCY1 mutations: Pathogenic variants cause autosomal dominant intellectual disability with seizures or [autism spectrum disorder](/diseases/autism-spectrum-disorder)[@ortega2013]
• cAMP homeostasis: Proper cAMP signaling is essential for neuronal development and circuit formation
• Synaptic development: Disrupted AC1 function affects dendritic spine morphology and synaptic connectivity

Expression Pattern

Brain Regions

ADCY1 shows neuron-specific expression with highest levels in[@visel2006]:

• Hippocampus: CA1-CA3 pyramidal cells, dentate gyrus granule cells
• Cerebral [Cortex](/brain-regions/cortex): Layer 2/3 and layer 5 pyramidal neurons
• Cerebellum: Purkinje cells
• Olfactory Bulb: Mitral and tufted cells
• Thalamus: Specific relay nuclei
• Basal Ganglia: Striatal medium spiny neurons

Subcellular Localization

• Plasma membrane: Integral membrane protein with 12 transmembrane domains
• Postsynaptic densities: Enriched in [dendritic spines](/cell-types/dendritic-spines)
• Synaptic vesicles: Associated with presynaptic terminals

Molecular Mechanisms

Calcium-Calmodulin Activation

AC1 contains a calmodulin-binding domain that mediates calcium-dependent activation:

This mechanism allows rapid cAMP production in response to calcium influx during synaptic activity, linking excitatory signaling to cAMP-dependent gene expression.

cAMP/PKA Signaling Cascade

Ca²⁺ influx → AC1 activation → cAMP ↑ → PKA activation
→ CREB phosphorylation → Gene transcription → Synaptic plasticity

Cross-talk with Other Pathways

ADCY1 participates in extensive signaling cross-talk:

• MAPK pathway: cAMP can activate Ras/Raf/MEK/ERK cascade
• PI3K/Akt: PKA phosphorylates Akt, affecting cell survival
• Calcium channels: PKA modulates voltage-gated calcium channels

Therapeutic Implications

Drug Development

ADCY1 is a potential therapeutic target for[@treseder2021]:

Challenges

• Brain penetration of small molecule modulators
• Isoform selectivity (AC1 vs. other ACs)
• Balancing cAMP levels (both too high and too low are problematic)

Animal Models

Knockout Studies

• ADCY1⁻/⁻ mice: Show impaired hippocampal [LTP](/mechanisms/long-term-potentiation) and memory deficits[@wie2004]
• Reduced anxiety: Knockout mice display anxiolytic-like behavior
• Learning deficits: Impaired contextual fear conditioning

Transgenic Models

• AC1 overexpression: Enhances memory in wild-type mice
• Mutant AC1: Models for intellectual disability show dominant-negative effects

Research Directions

Current research focuses on[@wang2023]:

Key Publications

See Also

• [ADCY5 Gene](/proteins/adcy5-protein) - Another neuronally-expressed adenylate cyclase
• [ADCY8 Gene](/adcy8-gene) - Calcium-activated AC isoform
• [cAMP Signaling Pathway](/mechanisms/camp-pathway) - cAMP-dependent pathways
• [PKA Protein](/proteins/pka-protein) - Protein kinase A
• [CREB1 Protein](/proteins/creb1-protein) - cAMP response element-binding protein
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Hippocampus](/brain-regions/hippocampus) - Brain region with high ADCY1 expression

External Links

• [NCBI Gene: ADCY1](https://www.ncbi.nlm.nih.gov/gene/107)
• [UniProt: Q08828](https://www.uniprot.org/uniprot/Q08828)
• [Ensembl: ENSG00000164742](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000164742)
• [GeneCards: ADCY1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADCY1)
• [OMIM: 612119](https://www.omim.org/entry/612119)

Conclusion

ADCY1 encodes a calcium/calmodulin-activated adenylate cyclase critical for neuronal cAMP production and synaptic plasticity. Its role in hippocampal memory formation, coupled with alterations in Alzheimer's and Parkinson's diseases, makes it an important therapeutic target. Understanding AC1 function and developing selective modulators may lead to treatments for cognitive disorders and neurodegenerative diseases. The unique calcium sensitivity of ADCY1 positions it as a key integrator of synaptic activity with downstream cAMP-dependent signaling cascades essential for learning and memory.

Background

The study of Adcy1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References